Dipeptidyl‐Peptidase 4 Inhibition and the Vascular Effects of Glucagon‐like Peptide‐1 and Brain Natriuretic Peptide in the Human Forearm

BACKGROUND: Dipeptidyl‐peptidase 4 (DPP4) inhibitors improve glycemic control in patients with diabetes mellitus by preventing the degradation of glucagon‐like peptide‐1 (GLP‐1). GLP‐1 causes vasodilation in animal models but also increases sympathetic activity; the effect of GLP‐1 in the human vasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Devin, Jessica K., Pretorius, Mias, Nian, Hui, Yu, Chang, Billings, Frederic T., Brown, Nancy J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310400/
https://www.ncbi.nlm.nih.gov/pubmed/25158865
http://dx.doi.org/10.1161/JAHA.114.001075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310400/
https://www.ncbi.nlm.nih.gov/pubmed/25158865
http://dx.doi.org/10.1161/JAHA.114.001075

Ejemplares similares